BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,066 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,719 | -24.8% | 51,394 | -3.9% | 0.01% | -30.0% |
Q1 2024 | $2,286 | +2.1% | 53,479 | -7.7% | 0.01% | 0.0% |
Q4 2023 | $2,240 | -18.1% | 57,934 | -20.3% | 0.01% | +42.9% |
Q3 2023 | $2,734 | -3.7% | 72,648 | +16.6% | 0.01% | -50.0% |
Q2 2023 | $2,840 | -13.9% | 62,327 | -23.3% | 0.01% | -17.6% |
Q1 2023 | $3,297 | -20.6% | 81,282 | -0.3% | 0.02% | -26.1% |
Q4 2022 | $4,155 | -99.9% | 81,511 | -0.2% | 0.02% | -8.0% |
Q3 2022 | $4,401,000 | -16.2% | 81,708 | -0.0% | 0.02% | -13.8% |
Q2 2022 | $5,250,000 | -17.5% | 81,741 | -0.4% | 0.03% | 0.0% |
Q1 2022 | $6,362,000 | -16.4% | 82,045 | -7.4% | 0.03% | -6.5% |
Q4 2021 | $7,606,000 | +5.3% | 88,602 | -1.4% | 0.03% | -3.1% |
Q3 2021 | $7,224,000 | -0.4% | 89,818 | -0.3% | 0.03% | 0.0% |
Q2 2021 | $7,251,000 | -5.1% | 90,071 | -0.5% | 0.03% | -11.1% |
Q1 2021 | $7,637,000 | +4.7% | 90,546 | -0.4% | 0.04% | +2.9% |
Q4 2020 | $7,296,000 | -2.3% | 90,921 | -2.0% | 0.04% | -12.5% |
Q3 2020 | $7,464,000 | -6.9% | 92,810 | -0.3% | 0.04% | -13.0% |
Q2 2020 | $8,015,000 | +7.2% | 93,085 | +1.0% | 0.05% | -11.5% |
Q1 2020 | $7,480,000 | +0.8% | 92,130 | +3.8% | 0.05% | +23.8% |
Q4 2019 | $7,420,000 | -4.4% | 88,729 | +0.0% | 0.04% | -10.6% |
Q3 2019 | $7,760,000 | +6.4% | 88,715 | -0.4% | 0.05% | +4.4% |
Q2 2019 | $7,292,000 | -2.2% | 89,040 | -2.9% | 0.04% | -6.2% |
Q1 2019 | $7,458,000 | +30.0% | 91,723 | +5.2% | 0.05% | +17.1% |
Q4 2018 | $5,738,000 | -14.8% | 87,172 | -0.2% | 0.04% | 0.0% |
Q3 2018 | $6,736,000 | +4.3% | 87,383 | -0.1% | 0.04% | -2.4% |
Q2 2018 | $6,459,000 | +13.1% | 87,477 | -0.4% | 0.04% | +10.5% |
Q1 2018 | $5,711,000 | -2.3% | 87,815 | -2.9% | 0.04% | +2.7% |
Q4 2017 | $5,847,000 | +6.8% | 90,458 | +3.6% | 0.04% | -5.1% |
Q3 2017 | $5,477,000 | -2.5% | 87,279 | -6.0% | 0.04% | -4.9% |
Q2 2017 | $5,619,000 | +16.6% | 92,820 | -0.2% | 0.04% | +10.8% |
Q1 2017 | $4,821,000 | +13.8% | 92,963 | -2.7% | 0.04% | +8.8% |
Q4 2016 | $4,237,000 | -12.6% | 95,560 | -6.2% | 0.03% | -12.8% |
Q3 2016 | $4,850,000 | +1.4% | 101,893 | -3.6% | 0.04% | -2.5% |
Q2 2016 | $4,781,000 | -2.6% | 105,722 | -11.5% | 0.04% | 0.0% |
Q1 2016 | $4,908,000 | -58.6% | 119,485 | -61.5% | 0.04% | -60.0% |
Q4 2015 | $11,850,000 | +15.9% | 310,621 | -0.2% | 0.10% | +11.1% |
Q3 2015 | $10,228,000 | -70.2% | 311,346 | -36.5% | 0.09% | -68.0% |
Q2 2015 | $34,287,000 | +58.4% | 490,303 | +55.1% | 0.28% | +57.9% |
Q1 2015 | $21,649,000 | -7.7% | 316,050 | -1.3% | 0.18% | -8.2% |
Q4 2014 | $23,458,000 | +1.9% | 320,077 | -0.2% | 0.19% | -1.5% |
Q3 2014 | $23,022,000 | -1.5% | 320,773 | -0.8% | 0.20% | 0.0% |
Q2 2014 | $23,380,000 | -3.7% | 323,372 | -2.0% | 0.20% | -5.3% |
Q1 2014 | $24,274,000 | -21.5% | 329,893 | -25.8% | 0.21% | -21.8% |
Q4 2013 | $30,929,000 | +4.6% | 444,707 | -1.2% | 0.27% | -2.6% |
Q3 2013 | $29,568,000 | -7.9% | 450,107 | -2.9% | 0.27% | -9.9% |
Q2 2013 | $32,111,000 | – | 463,559 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |